VP, Application Development
Momentum Biotechnologies
Dr. Peter Rye is VP, Application Development at Momentum Biotechnologies where he focuses on developing oligonucleotide and proteomics applications. Prior to Momentum he was a Pre-Sales Application Scientist at Agilent technologies for 12 years where he developed LC, RapidFire, and mass spec methods on a wide range of molecules. Before Agilent, Peter worked in the analytical development groups for BioTove and BIOCIUS, the original companies that developed the RapidFire platform.